Abivax SA - ADR

1
NAS:ABVX (France)   ADR
$ 7.60 +0.25 (+3.4%) 11:09 PM EST
At Loss
P/B:
2.27
Market Cap:
$ 465.62M
Enterprise V:
$ 237.32M
Volume:
116.31K
Avg Vol (2M):
118.63K
Trade In:
Volume:
116.31K
At Loss
Avg Vol (2M):
118.63K

Business Description

Description
Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. They are evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two most common forms are UC and CD.
Name Current Vs Industry Vs History
Cash-To-Debt 4.71
Equity-to-Asset 0.6
Debt-to-Equity 0.28
Debt-to-EBITDA -0.42
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 43.14
9-Day RSI 40.1
14-Day RSI 38.69
6-1 Month Momentum % -36.15
12-1 Month Momentum % -22.16

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 4.08
Quick Ratio 4.08
Cash Ratio 3.73

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -63.8
Shareholder Yield % -79.03

Financials (Next Earnings Date:2025-04-02 Est.)

ABVX's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:ABVX

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Abivax SA Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -3.559
Beta 0
Volatility % 38.55
14-Day RSI 38.69
14-Day ATR ($) 0.516625
20-Day SMA ($) 8.109
12-1 Month Momentum % -22.16
52-Week Range ($) 7 - 17.02
Shares Outstanding (Mil) 63.35

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Abivax SA Filings

Filing Date Document Date Form
No Filing Data

Abivax SA Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Abivax SA Frequently Asked Questions

What is Abivax SA(ABVX)'s stock price today?
The current price of ABVX is $7.60. The 52 week high of ABVX is $17.02 and 52 week low is $7.00.
When is next earnings date of Abivax SA(ABVX)?
The next earnings date of Abivax SA(ABVX) is 2025-04-02 Est..
Does Abivax SA(ABVX) pay dividends? If so, how much?
Abivax SA(ABVX) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1